Olema Pharmaceuticals Inc (NASDAQ:OLMA) price on current trading day, fall -0.72% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $4.11.
A look at the stock’s price movement, the close in the last trading session was $4.14, moving within a range at $4.1 and $4.75. Turning to its 52-week performance, $16.62 and $3.95 were the 52-week high and 52-week low respectively. Overall, OLMA moved -18.45% over the past month.
Olema Pharmaceuticals Inc’s market cap currently stands at around $280.85 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-17.
Turning to the stock’s technical picture we see that short term indicators suggest on average that OLMA is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend OLMA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
OLMA’s current price about -8.09% and -20.11% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 34.68, while 7-day volatility ratio is 8.20% and 7.65% in the 30-day chart. Further, Olema Pharmaceuticals Inc (OLMA) has a beta value of 2.06, and an average true range (ATR) of 0.38. Analysts have given the company’s stock an average 52-week price target of $27, forecast between a low of $27 and high of $27. Looking at the price targets, the low is -556.93% off current price level while to achieve the yearly target high, price needs to move -556.93%. Nonetheless, investors will most likely welcome a -556.93% jump to $27 which is the analysts’ median price.
If we refocus on Olema Pharmaceuticals Inc (NASDAQ:OLMA), historical trading data shows that trading volumes averaged 0.68 over the past 10 days and 1.03 million over the past 3 months. The company’s latest data on shares outstanding shows there are 57.29 million shares.
The 20.05% of Olema Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 84.43% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 8.47 million on 2025-02-28, giving us a short ratio of 8.99. The data shows that as of 2025-02-28 short interest in Olema Pharmaceuticals Inc (OLMA) stood at 1695.0001 of shares outstanding, with shares short rising to 8.41 million registered in 2025-01-31. Current price change has pushed the stock -29.50% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the OLMA stock continues to rise going into the next quarter.
